|
|
|
|
|
|
|
|
|
|
AGE |
TYPE |
ANS |
|
63 |
3 |
5 |
| TYPE DE RETINOPATHIE |
|
76 |
3 |
4 |
|
74 |
3 |
9 |
| TOTAL |
|
35 |
1 |
5 |
|
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
TOTAL RD |
|
87 |
4 |
28 |
| 37 |
3 |
25 |
5 |
3 |
1 |
|
9 |
|
83 |
4 |
5 |
| 100,00% |
8,11% |
67,57% |
13,51% |
8,11% |
2,70% |
|
24,32% |
|
91 |
4 |
10 |
|
73 |
3 |
14 |
|
|
66 |
4 |
15 |
|
80 |
4 |
14 |
|
77 |
3 |
12 |
|
75 |
3 |
5 |
|
63 |
4 |
13 |
|
72 |
3 |
9 |
|
54 |
3 |
25 |
|
58 |
3 |
22 |
|
57 |
4 |
7 |
|
66 |
1 |
25 |
|
80 |
3 |
4 |
|
63 |
3 |
7 |
|
63 |
4 |
15 |
|
54 |
1 |
19 |
|
53 |
4 |
14 |
|
19 |
1 |
19 |
|
63 |
3 |
1 |
|
84 |
3 |
15 |
| TOTAL INTERPRETABLE |
|
74 |
3 |
20 |
| |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
TOTAL RD |
|
64 |
3 |
5 |
| |
73,53% |
14,71% |
8,82% |
2,94% |
|
26,47% |
100,00% |
|
82 |
3 |
14 |
| |
25 |
5 |
3 |
1 |
|
9 |
34 |
|
70 |
2 |
1 |
|
69 |
2 |
1 |
|
58 |
4 |
4 |
|
|
74 |
3 |
23 |
|
75 |
3 |
4 |
|
63 |
4 |
19 |
|
79 |
4 |
19 |
|
79 |
4 |
9 |
|
|
|
| TOTAL OD + OG |
|
| |
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
|
|
| OD |
3 |
25 |
6 |
2 |
1 |
|
37 |
|
| OG |
4 |
25 |
5 |
2 |
1 |
|
37 |
|
| |
7 |
50 |
11 |
4 |
2 |
|
74 |
|
| OD |
8,11% |
67,57% |
16,22% |
5,41% |
2,70% |
|
100,00% |
|
| OG |
10,81% |
67,57% |
13,51% |
5,41% |
2,70% |
|
100,00% |
|
| MOYENNE |
9,46% |
67,57% |
14,86% |
5,41% |
2,70% |
|
100,00% |
|
|
| HOMMES |
|
| |
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
|
|
| OD |
3 |
15 |
4 |
1 |
1 |
|
24 |
|
| OG |
4 |
15 |
4 |
|
1 |
|
24 |
|
| |
7 |
30 |
8 |
1 |
2 |
|
48 |
|
| MAX |
|
15 |
4 |
1 |
|
|
20 |
|
| HOMMES |
|
75,00% |
20,00% |
5,00% |
|
|
100,00% |
|
| OD |
12,50% |
62,50% |
16,67% |
4,17% |
4,17% |
|
100,00% |
|
| OG |
16,67% |
62,50% |
16,67% |
|
4,17% |
|
100,00% |
|
| MOYENNE |
14,58% |
62,50% |
16,67% |
2,08% |
4,17% |
|
100,00% |
|
|
|
| FEMMES |
|
| |
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
|
|
| OD |
|
10 |
2 |
1 |
|
|
13 |
|
| OG |
|
10 |
1 |
2 |
|
|
13 |
|
| TOTAL |
|
20 |
3 |
3 |
|
|
26 |
|
| MAX/PATIENT |
|
10 |
1 |
2 |
|
|
13 |
|
| FEMMES |
|
76,92% |
7,69% |
15,38% |
|
|
100,00% |
|
| OD |
|
76,92% |
15,38% |
7,69% |
|
|
100,00% |
|
| OG |
|
76,92% |
7,69% |
15,38% |
|
|
100,00% |
|
| FEMMES |
|
76,92% |
11,54% |
11,54% |
|
|
100,00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|